S. Bastianetto et al., Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons, BR J PHARM, 131(4), 2000, pp. 711-720
1 Animal and epidemiological studies suggest that polyphenol constituents o
f red wine possess antioxidant activities that favour protection against ca
rdiovascular disease - the so-called. 'French paradox' - and possibly, cent
ral nervous system disorders such as Alzheimer's disease (AD) and ischaemia
.
2 In the present study, the potential of three major red wine derived-polyp
henols to protect against toxicity induced by the nitric oxide free radical
donors sodium nitroprusside (SNP) and 3-morpholinosydnonimine (SIN-1) was
examined in cultured rat hippocampal cells.
3 Both co- and post-treatments with either the stilbene resveratrol (5-25 m
uM) or the flavonoids quercetin (5-25 muM) and (+)-catechin (1-10 muM) were
capable of attenuating hippocampal cell death and intracellular reactive o
xygen species accumulation produced by SNP (100 muM and 1 mM, respectively)
. However, among the phenolic compounds tested, only the flavonoids afforde
d significant protection against 5 mM SIN-1-induced toxicity.
4 The effects of phenolic constituents were shared by Trolox (100 muM), a v
itamin E analogue, but not by selective inhibitors of cyclo-oxygenases (COX
) and lipoxygenases (LOX).
5 Among the phenolic compounds tested, only quercetin (10 muM) inhibited 10
0 muM SNP-stimulated protein kinase C (PKC) activation, whereas none of the
m were able to attenuate nitrite accumulation caused by SNP (100 muM).
6 Taken together, these data suggest that the neuroprotective abilities of
quercetin, resveratrol, and (+)-catechin result from their antioxidant prop
erties rather than their purported inhibitory effects on intracellular enzy
mes such as COX, LOX, or nitric oxide synthase. Quercetin, however, may als
o act via PKC to produce its protective effects.